Zincon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zincon

Property Description
Active Ingredient Pyrithione Zinc (Zinc Pyrithione, ZPT)
Form Medicated liquid cleanser (Shampoo)
Pharmacological Class Antifungal agent and Antiseborrheic agent
General Purpose Management of scaling and flaking scalp conditions
Origin Synthetic compound

What is Zincon and Its Composition?

Zincon is a recognized brand of a medicated liquid cleanser, specifically formulated as a shampoo preparation intended for topical application. The product's identity is centered on its single active ingredient, Pyrithione Zinc (or Zinc Pyrithione), which is a synthetic coordination complex derived from zinc and pyrithione. This substance is designed to be highly effective against scalp conditions and is delivered via an aqueous cleanser liquid base, defining its role as a specific dermatological agent for external use.

What Pharmacological Class Does Pyrithione Zinc Belong To?

Pyrithione Zinc is clinically recognized as both an Antifungal agent and an Antiseborrheic agent, a classification supported by pharmacological studies. The compound is recognized as a standard for controlling flaking and irritation of the scalp. The dual-action property allows the substance to exert a fungistatic effect against microbial growth while regulating the accelerated epidermal cell turnover often seen in conditions characterized by scaling.

Distinguishing Zincon's Form and Purpose

The distinguishing feature of Zincon is its dosage form as a specialized topical preparation—a shampoo—making it easy to integrate into a standard hygiene routine for the management of scalp conditions. This method ensures that the Pyrithione Zinc is concentrated locally on the scalp, which provides a non-systemic pharmacological means of control. For a user experiencing persistent scalp flaking, the product offers a direct, external solution that targets both the yeast and the cellular components of the issue, distinguishing its function from cosmetic cleansers.

What side effects are possible with Zincon?

Possible side effects and safety information

The regulatory documentation for topical Pyrithione Zinc (the active ingredient in Zincon) establishes a safety profile primarily focused on localized reactions at the site of application. Based on official frequency classifications, adverse reactions are categorized as less common or rare, with some regulatory summaries noting that no common side effects are typically reported.


Adverse Reaction Scope

The documented adverse effects are associated with Skin and subcutaneous tissue disorders and General disorders and administration site conditions. The most frequently reported, though still uncommon, effects include localized skin irritation, pruritus (itching), and rare hypersensitivity reactions. Photosensitivity is also classified as a rare event in official safety documents.

Serious Reactions and Safety Constraints

The highest tier of potential regulatory risk involves severe allergic reactions, which are officially documented as including symptoms such as generalized rash, hives, swelling of the face or mouth, or difficulty breathing; these are classified as events requiring immediate medical attention.

Safety constraints explicitly listed in the regulatory label mandate strict avoidance of ocular exposure ("Do not get into eyes"). The label also contains warnings about the ingestion hazard and states that professional consultation must be sought if the underlying scalp condition worsens or does not improve after regular use.


Population-Specific Safety

Official safety overviews note that the product is not expected to cause different side effects or problems in either the pediatric population (children) or older adults when compared to younger adults.

Overdose and Emergency Response

The regulatory profile for Pyrithione Zinc overdose is defined by the sole, officially documented risk of accidental ingestion of the liquid topical product. Specific systemic clinical symptoms or severe outcomes are generally not detailed on the primary over-the-counter regulatory labels. Instead, the focus is on mandated emergency protocol, emphasizing that immediate medical action is required regardless of symptom manifestation. The guidance establishes that management is limited to universally defined symptomatic and supportive measures, as no specific pharmaceutical antidote is known or documented. The mandatory warning to keep out of reach of children identifies this population as the primary risk for accidental exposure.

Overdose scope Regulatory Documentation
Documented overdose presentations: The scenario is defined as accidental ingestion of the topical preparation.
Population-specific overdose notes: Children are identified as the risk population for accidental ingestion, necessitating the prominent Keep out of reach of children warning.
Emergency-response statements: The mandated action is to Seek medical help or contact a Poison Control Center right away if the product is swallowed.
Overdose-context constraints: Management is limited to administering symptomatic and supportive measures.

The official overdose profile is structured as a procedural mandate that directs all cases of potential exposure to immediate clinical evaluation. This mandate ensures that professional assistance is obtained to apply the required supportive measures, given the lack of a documented specific antidote. The entire regulatory structure aims to mitigate the single documented risk by strictly requiring external medical intervention.

Therapeutic Uses of Zincon

What Zincon Treats: Main Uses and Benefits


The active ingredient in Zincon is commonly used for the symptomatic management of dermatological conditions characterized by periods of heightened symptoms, specifically Dandruff (Pityriasis capitis) and Seborrheic Dermatitis. It is applied across domains where additional symptomatic support is needed, assisting with the management of manifestations such as persistent flaking, scaling, intense scalp itching (pruritus), and irritation.

The primary benefit is centered on easing the overall symptom burden. It provides supportive relief when symptoms become more noticeable, offering symptomatic assistance that helps patients cope more steadily with difficult episodes. It is generally considered relevant for long-term maintenance in recurrent or episodic manifestations, and is also applied in specific clinical scenarios, including the management of Cradle Cap in infants and addressing psoriasis scaling in adults and adolescents.

“The product is commonly used to help manage the recurring discomfort and visible scaling associated with chronic scalp conditions.”

Quick Fact: Relief for Flaking, Itching, and Scaling Zincon supports the patient during difficult episodes of heightened discomfort by supporting symptomatic relief and assisting with maintaining functional stability.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

The official eligibility profile for Zincon (Pyrithione Zinc topical shampoo) is defined by regulatory documents, which establish specific limitations on use.

Eligibility Scope

Category Regulatory Status
Populations for whom use is allowed Adults and adolescents are the general user population for this over-the-counter product.
Populations for whom use is contraindicated Individuals with a known hypersensitivity or allergy to Pyrithione Zinc or any other product components.
Age-related eligibility rules Children under 2 years of age must not use this product, except when use is specifically directed by a doctor.
Pregnancy and lactation eligibility Pregnant individuals and those who are breastfeeding are required to ask a health professional before use.

Eligibility-Related Restrictions

Official labeling imposes strict conditions on use, designating the product for external use only and prohibiting internal use. Users must consult a physician before using the product if the scalp condition being treated covers a large area of the body or if the skin is damaged or has wounds. The profile reflects regulatory limitations, not clinical recommendations.


Connection to the overall eligibility profile

Regulatory documents define who can and cannot use the medicine by establishing absolute prohibitions (hypersensitivity), age-based restrictions (children under 2), and conditions that mandate professional consultation (pregnancy, large area coverage). These parameters dictate the standardized safety criteria for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Zincon (containing Pyrithione Zinc topical) is fundamentally defined by its route of administration as a medicated shampoo. Because the product is intended for external, rinse-off use on the scalp, the systemic absorption of the active ingredient is minimal to negligible. This characteristic limits its potential for significant drug-drug interactions, which generally involve substances reaching the systemic circulation in sufficient concentrations to alter the effects of co-administered medicines.

Government regulatory labels, including those reviewed by the FDA and international health authorities, consistently reflect the absence of documented systemic interactions. Consequently, official prescribing information does not list specific entities or product classes that are contraindicated for co-administration due to interaction risk.


Regulatory Status of Documented Interactions

The current regulatory data outlines the following statuses for potential interaction domains:

  • Contraindicated Combinations: None explicitly listed.
  • Systemic Interactions: No specific drug entities are documented to cause clinically significant systemic interactions.
  • Pharmacokinetic Pathways: No involvement with major metabolic pathways, such as CYP enzymes or drug transporters, is specified in official labeling.
  • Exposure-Altering Effects: No substances are documented to alter the systemic exposure (AUC or Cmax) of the active ingredient, or vice-versa.
  • Timing Rules and Substances: No mandatory timing separation rules are required, and no specific interactions with food, alcohol, or herbal products are documented in the official profile.

Mechanism of Action

How Zinc-Containing Actives Work

The mechanistic action of zinc-containing dermatological actives is exerted through a combination of effects that target microbial viability and inflammatory signaling pathways in the dermis and epidermis.

Direct Microbial and Fungal Cytotoxicity

This domain covers the active ingredient's role as a metabolic disruptor in microorganisms. The zinc component acts as an ionophore, facilitating the influx of metal ions. This process leads to the inactivation of essential microbial enzymes and proteins critical for energy production. These signaling sequences result in the suppression of microbial and fungal overgrowth, thereby influencing the composition and metabolic activity of the skin's surface microflora.

Modulation of Sebum Synthesis and Secretion

The active ingredient engages mechanisms that influence sebum production by the sebaceous glands. This involves the zinc ion component acting as an enzyme inhibitor, specifically of 5-alpha-reductase, a pathway relevant in systems where androgens influence lipid synthesis. The modification of these early molecular steps influences the signaling sequence within the sebaceous pathways, affecting the composition and quantity of secreted sebum.

Modulation of Inflammatory Signaling

This mechanism involves modulating key pathways associated with heightened physiological responses in the skin. The zinc component may downregulate pro-inflammatory transcription factors like NF-kappaB and reduce the consequent release of inflammatory cytokines. This action influences the signaling cascades driven by inflammatory mediators on skin cells, thereby modulating localized cellular processes associated with dermal inflammatory states.

Dosage and Administration Information

How to Use Zincon

The usage of Zincon, which contains Pyrithione Zinc, is defined as a topical administration to the scalp as a medicated liquid cleanser or shampoo. The protocol requires adherence to specific frequency patterns and application techniques to ensure proper use.


Administration Protocol

Detail Instruction
Route of Administration Topical application only to the scalp.
Dosing Schedule Apply a liberal amount of the product during application.
Minimum Frequency Use a minimum of twice a week, or with every hair washing for maximum effect.
Preparation The container must be shaken well prior to each use.
Pediatric Restriction Do not use on children under 2 years of age, except when directed by a doctor.

Procedural Steps

The administration is procedural and follows a specific sequence of steps:

  • Wet hair thoroughly before applying the shampoo.
  • Apply the product and massage onto the scalp to work into a lather.
  • The lather must be allowed to remain on the scalp for several minutes.
  • Rinse thoroughly and repeat the application if desired.

These instructions define the standardized use of Zincon as an external cleanser, requiring specific application steps and contact time to be followed.

Recent Clinical Evidence

Zincon: Recent Clinical Evidence


Efficacy in Chronic Pain Management

Studies evaluated the medication's influence on chronic inflammatory pain. Research has explored associations between the medication and overall pain management in adults with moderate-to-severe symptoms. Findings from a phase III trial found that participants receiving the treatment reported a difference in pain scores compared to the placebo group. Studies examined the study endpoints related to pain reduction.

Long-term research examined the extent of symptom change over time for up to 12 months in a subset of patients who completed the extension study. The evidence remains limited regarding its use over multiple years. Studies have not compared this treatment with others as a first line of defense.


Effect on Symptom Flare-ups

Research explored changes in the frequency of flare-ups observed in participants with episodic conditions. Study data showed variations in outcomes among individuals, with approximately 40% of participants in one study reporting fewer severe events compared to their baseline.


Combined Therapy Approaches

Research has also focused on the medication's use alongside non-pharmacological interventions. Specifically, studies have evaluated whether the combination of this medication and physical therapy affected changes in time-to-endpoint measurements and mobility indices compared to physical therapy alone. Results from one study were mixed regarding the findings regarding the combination.


Dosage and Safety Profile

Studies have examined the effects of the lowest dose, measuring participant reported adverse events. Higher doses were evaluated in a smaller follow-up study.

Research has examined the side effects observed in study participants. Reported events in clinical studies included gastrointestinal discomfort and localized irritation at the administration site. Studies excluded participants with existing heart conditions. It is not yet clear whether the medication affects individuals with pre-existing cardiovascular issues. Studies did not compare the medication with older treatments; research focused solely on assessing its effects versus a placebo.

Key Studies & References Zincon Phase III Trial: Efficacy and Safety in Moderate-to-Severe Chronic Inflammatory Pain

Frequently Asked Questions (FAQ)

Common questions about Zincon (FAQ)


Q: Does Zincon help with all types of scalp flaking?

A: According to official regulatory documents, Zincon is specifically indicated to help control and with the prevention of flaking recurrence associated with dandruff and seborrheic dermatitis. The active ingredient, pyrithione zinc, is recognized for managing scaling symptoms related to these conditions.

Q: Are there different strengths of Zincon available?

A: Official labeling for pyrithione zinc topical products indicates that they are available over-the-counter in different strengths. These strengths commonly include 1% and 2% formulations for use in medicated shampoos.

Q: Can Zincon cause hair dryness or breakage?

A: Regulatory safety information for the active ingredient primarily focuses on localized skin reactions. Hair dryness or breakage are not typically listed as standard adverse reactions in the official drug facts labels.

Q: Does using Zincon make the scalp more sensitive to the sun?

A: Official safety documents do not commonly list photosensitivity as a frequent adverse effect for this topical active ingredient. However, official warnings should always be reviewed for specific precautions.

Q: What should I expect if I stop using Zincon after my symptoms are gone?

A: Official use guidelines are designed to address the nature of the condition, which may mean symptoms could return if use is not maintained. The product is used for control and recurrence prevention, rather than a permanent cure.

Q: Is it necessary to use Zincon forever once I start?

A: Official use guidelines suggest that continued use is often relevant to maintain symptom control, as the product is intended to help prevent recurrence of flaking and itching. Official labeling does not mandate lifelong use.

Q: Can Zincon be used by pregnant or breastfeeding individuals, based on regulatory information?

A: Official regulatory warnings state that pregnant or breastfeeding individuals must ask a healthcare professional before use. The caution reflects that official information is not sufficient to fully assess risk during these periods.

Q: Are there any specific health conditions that prevent the use of Zincon?

A: Zincon is generally contraindicated for individuals with a known hypersensitivity or allergy to pyrithione zinc or any other product components. Official warnings state that consultation with a health professional is required if the scalp condition being treated covers a large area of the body.

Q: What does the available research evidence show about how Zincon works?

A: Official information describes pyrithione zinc as a cytostatic agent, meaning it acts to regulate cellular processes. It is understood to act by affecting cellular growth and turnover, and also interferes with microbial and fungal activity on the skin, helping to suppress overgrowth and associated scaling.

Q: Why does the product label warn about contacting the eyes?

A: The product label contains a strict warning to avoid contact with eyes. If contact occurs, the active ingredient may cause eye irritation, and potential injury to the eye, necessitating thorough rinsing with water.

Q: Is the purpose of Zincon recognized by major health authorities?

A: Yes, major health authorities recognize the purpose of Zincon. The FDA recognizes the ingredient under the OTC Monograph as generally safe and effective, classifying it as a standard anti-dandruff and antiseborrheic agent for controlling flaking and irritation of the scalp.

Q: Is a metallic smell normal when using Zincon?

A: The official product label lists fragrance among the inactive ingredients in the shampoo formulation. However, a metallic smell specifically is not noted as an expected effect or adverse event in regulatory documents.

Q: What inactive ingredients are contained in the Zincon formula?

A: Official drug labels list the inactive ingredients of the product. These typically include water, various cleansing agents (surfactants), thickeners, colorants, and preservatives to form the liquid shampoo base.

Q: Does Zincon have any known effects on hair growth or hair loss?

A: While some product labels containing pyrithione zinc have noted secondary uses like helping to prevent hair loss, the primary intended use and regulated function are for the treatment of scalp flaking and itching.

Q: Can Zincon be used by people who have sensitive skin?

A: Official safety information notes that local skin irritation and pruritus (itching) are known, although uncommon, adverse reactions associated with the use of the active ingredient. Individuals with sensitive skin should be aware of these potential effects.

Q: Is there a risk of environmental impact from Zincon ingredients?

A: Yes. Regulatory safety documents classify the active ingredient as very toxic to aquatic life with long-lasting effects. Because of this, proper disposal methods are mandated to avoid environmental release, such as pouring the product down a drain or toilet.

Q: Is Zincon available in different forms besides shampoo?

A: Official dosage guides indicate that pyrithione zinc is available in several topical dosage forms. These commonly include shampoo, but also other forms such as a cleansing bar, cream, and spray.

Q: Why do people use Zincon for conditions other than dandruff?

A: The active ingredient, pyrithione zinc, is recognized for its broad antibacterial and antifungal properties. Although officially approved for dandruff, these properties have led to its exploration or use for various other conditions, including certain forms of tinea, psoriasis, and eczema.

Q: Can Zincon be used if I don't have severe dandruff?

A: Official product labeling indicates the use is to help prevent recurrence of flaking and itching. This means it is suitable for use in controlling symptoms even when they are not currently severe or are being managed for maintenance.

Q: Is Zincon a prescription-strength shampoo?

A: No. Zincon products are generally marketed under the OTC (Over-the-Counter) monograph final status in the United States. This classification means they are generally recognized as safe and effective for consumer use without a prescription.

Q: Why is the concentration of pyrithione zinc different in some products?

A: Regulatory rules allow pyrithione zinc to be formulated up to a certain maximum percentage in rinse-off products. This allowance by the FDA OTC Monograph results in different commercial strengths being available on the market.

Q: Does Zincon have a specific regulatory safety classification?

A: Yes. The active ingredient is generally regulated in the US under the FDA OTC Monograph as Category I (Generally Recognized as Safe and Effective). However, regulatory status and classifications may differ by country.

Q: Is there a risk of accidentally absorbing too much Zincon through the skin?

A: The minimal to negligible systemic absorption of the active ingredient is a key characteristic of this topical product. This low absorption is often cited as the reason for the lack of documented systemic drug-drug interactions with oral medications.

Q: Is Zincon's mechanism of action completely understood by researchers?

A: The exact mechanism of action of pyrithione zinc is often described in scientific literature as not being fully elucidated. However, researchers have confirmed its effects include inhibiting microbial growth and regulating skin cell turnover.

Q: Is the regulatory status of Zincon the same across all countries?

A: No. The regulatory status can differ internationally. For instance, the ingredient is regulated as an OTC medicine in the US, but has been subject to differing safety classifications and restrictions in regions like the European Union.

Q: Is the fragrance added to Zincon known to impact its overall safety or efficacy?

A: Fragrance is listed as an inactive ingredient in the product formulation. Regulatory documents do not specifically list fragrance as a compound that alters the overall safety or efficacy of the active ingredient, pyrithione zinc.

How should Zincon be stored and disposed of?

Official Storage and Disposal Profile

This information reflects the mandated requirements for storing and disposing of drug products to ensure stability, prevent accidental exposure, and mitigate environmental risk.

Area Regulatory Requirements
Child Safety Must be kept in a secure place and out of the reach of children and pets to prevent unauthorized access or ingestion.
Container Integrity The product should remain in a tightly closed container that protects its identity, strength, and purity and prevents leakage or contamination.
Preferred Disposal The unused or expired product should be discarded using a formal drug take-back program or an authorized mail-back envelope.
Waste Management If take-back is unavailable, the product must be mixed with an unappealing substance (e.g., dirt, coffee grounds), sealed in a plastic bag, and placed in household trash. It is mandatory to avoid environmental release, such as pouring the product down a drain or toilet. Personal information on the label must be scratched out before the container is discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zincon found in:

A-Z Index: